Clinical Trial Update: A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules [Phase 4]

View source ↗

Summary

A multicenter Phase 4 trial reports tolerability of once-daily lopinavir/ritonavir liquid compared with capsules in HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• lopinavir/ritonavir liquid (lopinavir/ritonavir)

Snippet

Sponsor: University of California, San Diego | Conditions: HIV Infection | Phase 4 | Status: COMPLETED